BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: García-Vilas JA, Medina MÁ. Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications. World J Gastroenterol 2018; 24(33): 3695-3708 [PMID: 30197476 DOI: 10.3748/wjg.v24.i33.3695]
URL: https://www.wjgnet.com/1948-5182/full/v24/i33/3695.htm
Number Citing Articles
1
Hande Topel, Ezgi Bagirsakci, Dehan Comez, Gulsun Bagci, Gulcin Cakan-Akdogan, Nese Atabey. lncRNA HOTAIR overexpression induced downregulation of c-Met signaling promotes hybrid epithelial/mesenchymal phenotype in hepatocellular carcinoma cellsCell Communication and Signaling 2020; 18(1) doi: 10.1186/s12964-020-00602-0
2
Haiyu Wang, Benchen Rao, Jiamin Lou, Jianhao Li, Zhenguo Liu, Ang Li, Guangying Cui, Zhigang Ren, Zujiang Yu. The Function of the HGF/c-Met Axis in Hepatocellular CarcinomaFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00055
3
Bettina Bohusné Barta, Ágnes Simon, Lőrinc Nagy, Titanilla Dankó, Regina Eszter Raffay, Gábor Petővári, Viktória Zsiros, Anna Sebestyén, Ferenc Sipos, Györgyi Műzes, Vladimir Trajkovic. Survival of HT29 cancer cells is influenced by hepatocyte growth factor receptor inhibition through modulation of self-DNA-triggered TLR9-dependent autophagy responsePLOS ONE 2022; 17(5): e0268217 doi: 10.1371/journal.pone.0268217
4
Antonio Faiella, Ferdinando Riccardi, Giacomo Cartenì, Martina Chiurazzi, Livia Onofrio, Rengyun Liu. The Emerging Role of c-Met in Carcinogenesis and Clinical Implications as a Possible Therapeutic TargetJournal of Oncology 2022; 2022: 1 doi: 10.1155/2022/5179182
5
Wei Meng, Tao Chen. Association between the HGF/c‑MET signaling pathway and tumorigenesis, progression and prognosis of hepatocellular carcinoma (Review)Oncology Reports 2021; 46(3) doi: 10.3892/or.2021.8142
6
Pradeep Madhamanchi, Kishore Madhamanchi, Sujatha Peela, Panchareddy Madhava Rao, Pallaval Veera Bramhachari, Prakash Babu Panithi. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 22022; : 255 doi: 10.1016/B978-0-323-98807-0.00021-1
7
Min Hee Yang, Seung Ho Baek, Jae-Young Um, Kwang Seok Ahn. Anti-neoplastic Effect of Ginkgolide C through Modulating c-Met Phosphorylation in Hepatocellular Carcinoma CellsInternational Journal of Molecular Sciences 2020; 21(21): 8303 doi: 10.3390/ijms21218303
8
Ujjwala Karmacharya, Diwakar Guragain, Prakash Chaudhary, Jun-Goo Jee, Jung-Ae Kim, Byeong-Seon Jeong. Novel Pyridine Bioisostere of Cabozantinib as a Potent c-Met Kinase Inhibitor: Synthesis and Anti-Tumor Activity against Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2021; 22(18): 9685 doi: 10.3390/ijms22189685
9
Yi Zhang, Binyong Liang, Xinhua Song, Haichuan Wang, Matthias Evert, Yi Zhou, Diego F. Calvisi, Liling Tang, Xin Chen. Loss of Apc Cooperates with Activated Oncogenes to Induce Liver Tumor Formation in MiceThe American Journal of Pathology 2021; 191(5): 930 doi: 10.1016/j.ajpath.2021.01.010
10
Hande Topel, Ezgi Bağırsakçı, Yeliz Yılmaz, Ayşim Güneş, Gülsün Bağcı, Dehan Çömez, Erkan Kahraman, Peyda Korhan, Neşe Atabey. High glucose induced c-Met activation promotes aggressive phenotype and regulates expression of glucose metabolism genes in HCC cellsScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-89765-5
11
Wancheng Qiu, Yanhua Chang, Jing Liu, Xu Yang, Yan Yu, Jiajia Li, Qing Liang, Guangchun Sun. <p>Identification of P-Rex1 in the Regulation of Liver Cancer Cell Proliferation and Migration via HGF/c-Met/Akt Pathway</p>OncoTargets and Therapy 2020; : 9481 doi: 10.2147/OTT.S265592
12
Chiara Fedeli, Hector Moreno, Stefan Kunz. The Role of Receptor Tyrosine Kinases in Lassa Virus Cell EntryViruses 2020; 12(8): 857 doi: 10.3390/v12080857
13
Qin He, Zhuoying Lin, Zhihui Wang, Wenjie Huang, Dean Tian, Mei Liu, Limin Xia. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-METOncogene 2020; 39(50): 7279 doi: 10.1038/s41388-020-01500-y
14
Neha Merchant, Afroz Alam, Sujatha Peela, Ganji Purnachandra Nagaraju. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 22022; : 273 doi: 10.1016/B978-0-323-98807-0.00025-9
15
Chao Wu, Zuowei Wu, Bole Tian. Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancerBMC Surgery 2020; 20(1) doi: 10.1186/s12893-020-00856-y
16
Daniel Neureiter, Sebastian Stintzing, Tobias Kiesslich, Matthias Ocker. Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targetsWorld Journal of Gastroenterology 2019; 25(25): 3136-3150 doi: 10.3748/wjg.v25.i25.3136
17
Elisa Holstein, Mathias Binder, Wolfgang Mikulits. Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for TheranosticsInternational Journal of Molecular Sciences 2018; 19(12): 4111 doi: 10.3390/ijms19124111
18
Xin Liu, Ranran Sun, Jianan Chen, Liwen Liu, Xichun Cui, Shen Shen, Guangying Cui, Zhigang Ren, Zujiang Yu. Crosstalk Mechanisms Between HGF/c-Met Axis and ncRNAs in MalignancyFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00023
19
Jill Koshiol, Ilona Argirion, Zhiwei Liu, Tram Kim Lam, Thomas R. O’Brien, Kelly Yu, Katherine A. McGlynn, Jessica L. Petrick, Ligia Pinto, Chien‐jen Chen, Allan Hildesheim, Ruth M. Pfeiffer, Mei‐Hsuan Lee, Hwai‐I Yang. Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus‐ and hepatitis C virus‐infected individualsAlimentary Pharmacology & Therapeutics 2021; 54(6): 833 doi: 10.1111/apt.16524
20
Cyril Garcia, Camille Buffet, Laila El Khattabi, Marthe Rizk-Rabin, Karine Perlemoine, Bruno Ragazzon, Jérôme Bertherat, Françoise Cormier, Lionel Groussin. MET overexpression and activation favors invasiveness in a model of anaplastic thyroid cancerOncotarget 2019; 10(23): 2320 doi: 10.18632/oncotarget.26798
21
Birgit Lohberger, Susanne Scheipl, Ellen Heitzer, Franz Quehenberger, Danielle de Jong, Karoly Szuhai, Bernadette Liegl-Atzwanger, Beate Rinner. Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordomaScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92018-0
22
Mingyuan Zhao, Yinhe Wang, Yan Liu, Wanchun Zhang, Yakun Liu, Xiaoming Yang, Yunxia Cao, Siying Wang. C7 peptide inhibits hepatocellular carcinoma metastasis by targeting the HGF/c-Met signaling pathwayCancer Biology & Therapy 2019; 20(12): 1430 doi: 10.1080/15384047.2019.1647051
23
Nehad M. Ayoub, Amer E. Alkhalifa, Dalia R. Ibrahim, Ahmed Alhusban. Combined crizotinib and endocrine drugs inhibit proliferation, migration, and colony formation of breast cancer cells via downregulation of MET and estrogen receptorMedical Oncology 2021; 38(1) doi: 10.1007/s12032-021-01458-1
24
Cindy Lobe, Marie Vallette, Ander Arbelaiz, Ester Gonzalez‐Sanchez, Laura Izquierdo, Anna Pellat, Nathalie Guedj, Corentin Louis, Valérie Paradis, Jesus M Banales, Cédric Coulouarn, Chantal Housset, Javier Vaquero, Laura Fouassier. Zinc Finger E‐Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor–Stroma Paracrine SignalingHepatology 2021; 74(6): 3194 doi: 10.1002/hep.32069
25
M. Murali, A. R. Kumar, B. Nair, K. Pavithran, A. R. Devan, G. K. Pradeep, L. R. Nath. Antibody–drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevanceClinical and Translational Oncology 2022; 24(3): 407 doi: 10.1007/s12094-021-02707-5
26
Zhiwei Shao, Haoqi Pan, Sheng Tu, Jingying Zhang, Sheng Yan, Anwen Shao. HGF/c-Met Axis: The Advanced Development in Digestive System CancerFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00801
27
Christian Liedtke, Yulia A. Nevzorova, Tom Luedde, Henning Zimmermann, Daniela Kroy, Pavel Strnad, Marie-Luise Berres, Jürgen Bernhagen, Frank Tacke, Jacob Nattermann, Ulrich Spengler, Tilman Sauerbruch, Alexander Wree, Zeinab Abdullah, René H. Tolba, Jonel Trebicka, Twan Lammers, Christian Trautwein, Ralf Weiskirchen. Liver Fibrosis—From Mechanisms of Injury to Modulation of DiseaseFrontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.814496
28
Qin-Liang Fang, Jian-Yin Zhou, Yu Xiong, Cheng-Rong Xie, Fu-Qiang Wang, Yun-Tong Li, Zhen-Yu Yin, Guo-Hui Luo. Long non-coding RNA RP11-284P20.2 promotes cell proliferation and invasion in hepatocellular carcinoma by recruiting EIF3b to induce c-met protein synthesisBioscience Reports 2020; 40(3) doi: 10.1042/BSR20200297
29
Ishfaq Hassan Mir, K. C. Jyothi, Chinnasamy Thirunavukkarasu. The prominence of potential biomarkers in the diagnosis and management of hepatocellular carcinoma: Current scenario and future anticipationJournal of Cellular Biochemistry 2021;  doi: 10.1002/jcb.30190
30
Haixing Liao, Muneeb Ahmed, Aurelia Markezana, Guohua Zeng, Matthias Stechele, Eithan Galun, S. Nahum Goldberg. Thermal Ablation Induces Transitory Metastatic Growth by Means of the STAT3/c-Met Molecular Pathway in an Intrahepatic Colorectal Cancer Mouse ModelRadiology 2020; 294(2): 464 doi: 10.1148/radiol.2019191023
31
Valeria De Pasquale, Luigi Michele Pavone. Heparan Sulfate Proteoglycan Signaling in Tumor MicroenvironmentInternational Journal of Molecular Sciences 2020; 21(18): 6588 doi: 10.3390/ijms21186588
32
Stefano Cavalieri, Francesca Platini, Cristiana Bergamini, Carlo Resteghini, Donata Galbiati, Paolo Bossi, Federica Perrone, Elena Tamborini, Pasquale Quattrone, Lisa Licitra, Laura Deborah Locati, Salvatore Alfieri. Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?Expert Opinion on Investigational Drugs 2019; 28(5): 435 doi: 10.1080/13543784.2019.1598376
33
Mohamed Omran, Manar Fouda, Abdelwahab Osama Abdelwahab, Mohamed Mahmoud Nabeel, Ashraf Omar Abdelaziz, Dalia Omran, Hend Ibrahim Shousha. P53 is a risk factor of de-novo hepatitis C-related hepatocellular carcinoma treated with direct-acting antivirals: a case-control studyEuropean Journal of Gastroenterology & Hepatology 2022; 34(2): 220 doi: 10.1097/MEG.0000000000001962
34
Shenjun Yuan, Yuyuan Gong, Ruobing Chen, Juan Du, Hongfeng Zhang, Tao Chen. Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathwayBiomedicine & Pharmacotherapy 2020; 132: 110867 doi: 10.1016/j.biopha.2020.110867
35
Zahra Farzaneh, Massoud Vosough, Tarun Agarwal, Maryam Farzaneh. Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approachesCancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01924-w